The current article briefly reviews the projects of development of combat burn injury treatment as they have been presented in the US Armed Forces Institute of Regenerative Medicine 2013 annual report. Eleven projects have been reviewed, in particular: P12 polypeptide for limiting burn injury progression, gamma keratose gelfor enhancement skin cell survival, starch-polyurethane iodophor dressing effective against the most common burn infection, microorganisms, autologous stem and progenitor cells for single cell cytotransplantation by "skin gun" spray device or 3D skin bioprinting, a bioreactor for skin autotransplant expansion.